Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Contemp Clin Trials. 2021 Sep 20;110:106571. doi: 10.1016/j.cct.2021.106571

Table 1.

Virtual scenarios (rate of ePTB) for evaluating dose-response relationship for the effect of DHA.

Dose (g/day)
Scenario 0 (n=350) 0.2 (n=700) 0.45 (n=175) 0.6 (n=180) 0.8 (n=150) 1 (n=550)
1 (optimistic) 6.27% 4.90% 3.91% 3.52% 3.13% 2.85%
2 (expected) 3.34% 2.60% 2.00% 1.74% 1.47% 1.27%
3 (pessimistic) 1.56% 1.17% 0.87% 0.75% 0.63% 0.54%
4 (no effect) 3.34% 3.34% 3.34% 3.34% 3.34% 3.34%